By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
Preview - This content has been restricted to logged in users only.
In vivo absorption and human pharmacokinetics predicted from in vitro dissolution/permeability data using a Gastrointestinal Unified Theoretical (GUT) framework-based absorption model.
The data presented in this poster presented at the 2023 AAPS PharmSci 360 illustrates the applicability of in vitroflux assays in conjunction with predictive modelling software to predict the relative in vivoperformanceof formulations containing nanoformed Piroxicam.